Company profile: VasoNova
1.1 - Company Overview
Company description
- Provider of medical devices, including a self-guided PICC catheter; develops, manufactures, and markets these products. Based in Sunnyvale, California.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to VasoNova
Preventice Solutions
HQ: United States
Website
- Description: Provider of mobile cardiac health solutions and remote monitoring services, connecting patients, clinicians, and hospitals. Offerings include BodyGuardian wearable waterproof ECG monitors and BodyGuardian MINI PLUS for mobile cardiac telemetry; the HIPAA-compliant PatientCare platform for near-real-time data management; and service models from full-service monitoring to equipment and software purchase options.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Preventice Solutions company profile →
ivWatch
HQ: United States
Website
- Description: Provider of intravenous infiltration detection solutions, including the ivWatch Monitoring System that continuously monitors peripheral IVs to detect infiltrations and extravasations early with real-time notifications to clinicians; SmartTouch single-use sensor and reusable optical fiber sensor for flexible, comfortable, MRI-compatible IV site monitoring; and OEM solutions to embed the technology into patient monitors or infusion pumps.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ivWatch company profile →
DalCor Pharmaceuticals
HQ: Canada
Website
- Description: Provider of pharmacogenetic precision treatments for cardiovascular disease targeting patients with the ADCY9 AA genotype, including dalcetrapib; the completed Dal-GenE (DAL-301) cardiovascular outcomes trial; the Phase 3 Dal-GenE-2 (DAL-302) trial evaluating dalcetrapib’s potential to reduce fatal and non-fatal myocardial infarction; and the cobas ADCY9 genotype companion diagnostic developed with Roche Molecular Systems.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DalCor Pharmaceuticals company profile →
Capstan Medical
HQ: United States
Website
- Description: Provider of minimally invasive catheter-based technologies for heart valve disorders, including the Capstan Platform for treating mitral and tricuspid valve disease while the heart is beating, precision heart valve implants placed through a catheter, and surgical robotics integration to enhance procedure accuracy and reliability, offering a less invasive alternative to open heart surgery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Capstan Medical company profile →
Conavi Medical
HQ: Canada
Website
- Description: Provider of image guidance technologies for minimally invasive cardiovascular procedures, including catheter-based ultrasound that generates 2-D and 3-D images of intracardiac and intravascular anatomy around the catheter tip, and the Novasight Hybrid System, which combines intravascular ultrasound (IVUS) and optical coherence tomography (OCT).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Conavi Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for VasoNova
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to VasoNova
2.2 - Growth funds investing in similar companies to VasoNova
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for VasoNova
4.2 - Public trading comparable groups for VasoNova
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →